key: cord-0732358-yrw9you3
authors: Lee, Nicholas C.J.; Patel, Bhavisha; Etra, Aaron; Bat, Taha; Ibrahim, Ibrahim F.; Vusirikala, Madhuri; Chen, Mingyi; Rosado, Flavia; Jaso, Jesse; Young, Neal S.; Chen, Weina
title: SARS-CoV-2 Infection Associated with Aplastic Anemia and Pure Red Cell Aplasia
date: 2022-04-26
journal: Blood Adv
DOI: 10.1182/bloodadvances.2022007174
sha: 566b7aedac52ae718d6734bff006906751f32785
doc_id: 732358
cord_uid: yrw9you3

nan

Patient #2 is a 69-year-old Asian female who presented with symptoms of fatigue and was found to 54 be pancytopenic. Complete blood count from a few months prior was normal. Further work-up was 55 positive for SARS-CoV-2 PCR and negative for other viral and nutritional deficiencies. Her SARS-

CoV-2 PCR cycle threshold was 36 and IgG was positive, suggesting persistent viral shedding and 57 remote infection. She did not have respiratory symptoms and was diagnosed with severe AA based 58 on a hypocellular marrow and pancytopenia. She underwent treatment with cyclosporine, equine 59 antithymocyte globulin (hATG), and eltrombopag. She has had a partial response to therapy at her 60 last follow-up of 10 months. Patients #1 and 2 had bone marrow specimens stained for SARS-CoV-2 61 by immunohistochemistry that were negative.

Patient #3 is a 76-year-old white male who was diagnosed with COVID-19 4 months prior to 64 presenting with a non-ST segment myocardial infarction and was found to be profoundly anemic, requiring PRBC transfusion. He re-presented with chest pain one week later and was found to have 3 transfusion-dependent anemia. A brief trial with the erythropoietin stimulating agent darbepoetin alfa 67 was unsuccessful. Extensive work-up for malignancy (including thoracic and abdominopelvic CT 68 imaging), infection, and autoimmune etiologies were negative. He was diagnosed with acquired 69 PRCA based on the bone marrow biopsy and initiated treatment with cyclosporine. He was 70 transitioned to tacrolimus due to a medication interaction, and he has had a CR at 3 months and 71 remains well at last follow-up. 

Patient #5 is a 69-year-old white female who had mild COVID-19 infection managed at home five 83 months prior to presenting with bruising and was found to have severe pancytopenia. Her infectious, 84 malignant, and autoimmune evaluation were negative, although she had minute PNH clones. She 85 was diagnosed with platelet transfusion-dependent severe AA (5% cellularity on bone marrow) and 86 has initiated cyclosporine, ATG, and eltrombopag therapy less than a month ago, and it is too early 87 to determine an immunosuppression therapy response.

Patient #6 is a 28-year-old female who had COVID-19 and bruising three months prior to presenting 90 with pancytopenia; part of her clinical course was previously reported. 3 While her initial and repeat 91 bone marrow biopsies revealed 20-30% marrow cellularity, there was near absence of erythroid 92 precursors and megakaryocytes and the patient was pRBC and platelet transfusion-dependent.

There was no evidence of malignancy on cytogenetic array, or NGS assessment, and severe AA 94 was suspected. No PNH clone was identified, and although telomere length was shorter than 

We report six cases of new-onset of acquired marrow failure in patients with SARS-CoV-2 infection.

A similar case series was reported recently, including 4 adult AA cases diagnosed a few weeks after VSAA was defined as an ANC of <200/μL. PR was defined as blood counts no longer meeting the standard 'Camitta' criteria: ANC of ≥500/μL, platelet count ≥20,000/μL, and absolute reticulocyte count of ≥60,000/μL. CR was defined as absolute ANC of >1000/μL, platelet count of ≥100,000/μL, and hemoglobin ≥10g/L. *quantitative data presented as median. † Marked erythroid hypoplasia. ‡ No dividing cells found; could not evaluate karyotype. § : -X likely representing age related changes.

BMBx-IHC = bone marrow biopsy by immunohistochemistry, using mouse monoclonal antibody against SARS-CoV/SARS-CoV-2 nucleocapsid protein, SinoBiological, 40143-MM05). ¶ While these patients had a short duration between positive PCR testing and pancytopenia observed, their initial infections may be weeks to months prior to developing pancytopenia. ALC indicates absolute lymphocyte count; ANC, absolute neutrophil count; CBC, peripheral blood cell count; CR, complete response; CsA, cyclosporine; EPAG, eltrombopag; F, female; h-ATG, horse antithymocyte globulin; Hgb, hemoglobin; HSCT, hematopoietic stem cell transplant; IST, immune suppressive therapy; L, low; LD-MTX, lowdose methotrexate; MCV, mean corpuscular volume; NA, not applicable; NGS, next generation sequencing a large panel of genes in hematolymphoid neoplasms; PCR, polymerase chain reaction; PLT, platelet count; PR, partial response; PRCA, pure red cell aplasia; SAA, severe aplastic anemia; WBC, white cell count

Aplastic Anemia

COVID-19 infection in patients with